A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...
A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.
New research suggests a universal cancer vaccine may be on the horizon. Scientists found a "generalized" mRNA vaccine boosted the tumor-fighting effects of immunotherapy. The University of Florida ...
An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results